Insider filing · UPXI

Gene Salkind bought $550K of Upexi (UPXI)

Executed Apr 17 2025, disclosed Apr 25 2025, 8 days later, against a two-business-day limit.

Over the 21 trading sessions from the disclosed entry session (Apr 25 2025), the stock returned -22.9% (delay-adjusted); from the execution session (Apr 17 2025), +321.1%. Derived: entry at the session's open, exit at the close 20 sessions later.

GS Gene Salkind Director profile →

Gene Salkind (Director) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in UPXI. Across 2 priced purchase filings, the average 21-session return was -27.4% from execution and -19.7% from disclosure (delay-adjusted; derived). The largest single filing was $546K of UPXI (200,000 sh across 2 lots, as filed), executed Nov 17 2025.

UPXI UPXI UPXI · 8 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→